GLGLENVIEW CAPITAL MANAGEMENT, LLC
Institutional investor · Portfolio as of Q1 2026
Top Holdings44 positions
CVS HEALTH CORP | 8.2M | $588.7M | 14.8% | $57.60 | +22.84% | 10 qtrssince 2023-Q4 | Unchanged 0 |
GLOBAL PMTS INC | 6.4M | $428.1M | 10.7% | $105.22 | -36.47% | 22 qtrssince 2020-Q4 | Increased 66 |
TENET HEALTHCARE CORP COM NEW | 1.5M | $287.8M | 7.2% | $55.85 | +237.90% | 30 qtrssince 2018-Q4 | Decreased 0 |
Amazon.com, Inc. | 1.1M | $220.6M | 5.5% | $193.35 | +7.72% | 13 qtrssince 2023-Q1 | Increased 70 |
TEVA PHARMACEUTICAL INDS LTD | 6.7M | $200.6M | 5.0% | $14.97 | +101.24% | 10 qtrssince 2023-Q4 | Decreased 0 |
Invesco QQQ Trust, Series 1 UNIT SER 1 | 328,200 | $189.4M | 4.8% | — | — | — | New — |
CIGNA CORP NEW | 498,841 | $133.1M | 3.3% | $252.33 | +4.53% | 30 qtrssince 2018-Q4 | Increased 85 |
ADVANCED MICRO DEVICES INC | 650,792 | $132.4M | 3.3% | $209.93 | -3.10% | 2 qtrssince 2025-Q4 | Increased 82 |
Thermo Fisher Scientific Inc | 250,525 | $123.1M | 3.1% | $458.94 | +6.91% | 4 qtrssince 2025-Q2 | Increased 63 |
VIATRIS INC COM | 9.1M | $122.8M | 3.1% | $10.67 | +24.80% | 10 qtrssince 2023-Q4 | Decreased 0 |
DXC TECHNOLOGY CO | 8.9M | $111.8M | 2.8% | $25.05 | -50.49% | 30 qtrssince 2018-Q4 | Increased 56 |
CENTENE CORP DEL | 3.2M | $105.2M | 2.6% | $36.96 | -11.43% | 3 qtrssince 2025-Q3 | Increased 78 |
Uber Technologies Inc | 1.5M | $104.7M | 2.6% | $75.33 | +1.36% | 20 qtrssince 2021-Q2 | Increased 84 |
ZOOMINFO TECHNOLOGIES INC COMMON STOCK | 15.9M | $95.1M | 2.4% | $10.59 | -63.37% | 8 qtrssince 2024-Q2 | Decreased 0 |
iShares Trust RUSSELL 2000 ETF | 375,000 | $93M | 2.3% | — | — | — | New — |
SQUARE INC | 1.4M | $82.1M | 2.1% | $66.87 | -5.94% | 3 qtrssince 2025-Q3 | Increased 74 |
Meta Platforms Inc | 122,662 | $70.2M | 1.8% | $580.69 | -1.64% | 5 qtrssince 2025-Q1 | Increased 76 |
APPLIED MATLS INC | 197,209 | $67.4M | 1.7% | $285.47 | +19.58% | 2 qtrssince 2025-Q4 | Increased 66 |
Onto Innovation Inc. | 299,721 | $61.5M | 1.5% | $140.69 | +47.48% | 3 qtrssince 2025-Q3 | Decreased 0 |
DICKS SPORTING GOODS INC COM | 298,911 | $59.3M | 1.5% | $195.78 | -0.23% | 4 qtrssince 2025-Q2 | Increased 50 |
GLENVIEW CAPITAL MANAGEMENT, LLC manages $4B across 44 positions as of Q1 2026. Top holdings: CVS (14.8%), GPN (10.7%), THC (7.2%). Fund DNA: Balanced Allocator. HoldingsIntel Score: 3/5.0.
Active quarter - 6 new positions, 19 exits, 17 increased. Top move: CI (INCREASED, conviction 85). Portfolio: $4.0B across 44 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR